2025-11-26T13:55:17-06:00 2025-06-30 742752212 MASSEY ITSCHNER & CO PC 820 MAIN STREET SUITE 101 KERRVILLE TX 78028 990EZ 2024-07-01 874397344 COALITION OF PET DRUG MANUFACTURERS INC COAL 8303706554 223 GREEN OAKS LOOP FREDERICKSBURG TX 786244576 CHARLES METZGER EXECUTIVE DIRECTOR 8303706554 2025-11-25 1 1 CASEY T MIKESKA P01435690 8302575330 2025-11-25 2024 2025-03-06 01:10:19Z X X WWW.PETDRUGMANUFACTURERS.ORG X X 47500 X 47500 47500 36925 8644 45569 1931 64081 0 66012 64081 66012 64081 66012 0 0 64081 66012 X THE COALITION OF PET DRUG MANUFACTURERS (CPDM) IS A VENUE FOR THE POSITRON EMISSION TOMOGRAPHY (PET) DRUG MANUFACTURING COMMUNITY TO ADVANCE SCIENTIFIC AND REGULATORY PRINCIPLES ASSOCIATED WITH THE MANUFACTURING OF PET DRUGS. THE KEY PURPOSES OF THIS MISSION ARE TO: PROVIDE A MULTI-STAKEHOLDER FORUM TO ADDRESS CURRENT TOPICS WITH GOVERNMENT AGENCIES AND OTHER GROUPS; ESTABLISH SCIENTIFICALLY SOUND AND RATIONAL PRACTICES FOR PET DRUG MANUFACTURING; PROVIDE EDUCATION AND TRAINING; ENABLE THE EXPANSION OF NEW PET DRUGS INTO ROUTINE MANUFACTURING NETWORKS; PROVIDE HIGH-VALUE RESOURCES TO ASSIST PET DRUG MANUFACTURERS WITH GMP COMPLIANCE AND INSPECTION CHALLENGES; ALIGN THE INTERESTS OF THE COMMUNITY OF PET DRUG MANUFACTURERS; AND TO ENGAGE IN ANY AND ALL LAWFUL ACTIVITIES TO ACCOMPLISH THE FOREGOING PRIMARY PURPOSE AND OBJECTIVES, EXCEPT AS RESTRICTED HEREIN. OVER THE PAST YEAR, THE COALITION HAS ADVANCED ITS MISSION THROUGH A WIDE RANGE OF IMPACTFUL INITIATIVES. WE STRENGTHENED MEMBER INTERACTION BY CREATING A DEDICATED WHATSAPP GROUP AND HELD OUR FIRST BOARD MEMBER ELECTION, WHILE ALSO APPOINTING MICHAEL NAZERIAS AS OUR REPRESENTATIVE TO THE IAEA TECHNICAL WORKING GROUP FOR RADIOPHARMACEUTICAL MEDICINES REGULATIONS. KEY INFRASTRUCTURE DEVELOPMENTS INCLUDED CREATING AN FDA 483 AND IR DATABASE, PRODUCING A COMPREHENSIVE 35 YEAR STRATEGIC PLAN, AND ESTABLISHING THREE NEW WORKING GROUPSMEMBERSHIP EDUCATION AND TRAINING, MEMBERSHIP ENGAGEMENT, AND NEW MEMBER RECRUITMENTTO DRIVE THE PLAN'S OBJECTIVES. OUR SCHOLARLY AND REGULATORY CONTRIBUTIONS WERE SIGNIFICANT, WITH THE PROCEEDINGS FROM THE 2023 FDA WORKSHOP NOW IN PRESS AT JNM, THE PUBLICATION OF A POSITION PAPER ON STABILITY STUDIES, A JNM LETTER TO THE EDITOR ON FDA RECONSIDERATIONS AROUND DOSIMETRY RULES FOR FIRST-IN-HUMAN PET DRUG STUDIES, AND A SPOTLIGHT ARTICLE FEATURING KRISHNA GHOSH. WE ALSO COLLABORATED ON DRAFTING A MITA LETTER TO THE FDA REGARDING PRECURSOR TESTING. AT THE SNMMI CONFERENCE, THE COALITION PARTNERED WITH RPSC TO ORGANIZE A CE SESSION, DELIVERED PRESENTATIONS AND POSTERS ON ADVERSE EVENTS AND STERILITY ASSURANCEINCLUDING A POSTER AWARD CANDIDATEAND HOSTED A KIOSK IN THE EXHIBIT HALL TO ENGAGE ATTENDEES AND SHARE RESOURCES. 0 0 SUSAN K BUNNING DIRECTOR 1.50 0 0 0 CHRISTOPHER C IGNACE SECRETARY 1.50 0 0 0 CHARLES METZGER EXECUTIVE DIRECTOR 8.00 0 0 0 PETER SCOTT TREASURER 1.50 0 0 0 HENRY VANBROCKLIN CO-CHAIR 2.00 0 0 0 STEVEN ZIGLER CO-CHAIR 2.00 0 0 0 DAVID DICK DIRECTOR 1.50 0 0 0 SHARON LEE DIRECTOR 1.50 0 0 0 X 0 0 0 0 0 0 0 0 METZGER MABRY & ASSOCIATES 223 GREEN OAKS LOOP FREDERICKSBURG TX 78624 8303706554 0 0 0 0 0 0 0 FORM 990-EZ, PART I, LINE 16 - OTHER EXPENSES DESCRIPTION: CREDIT CARD & BANK FEES. AMOUNT: 471. DESCRIPTION: MEETING/TRAVEL EXPENSE. AMOUNT: 8,173. TOTAL TO FORM 990-EZ, LINE 16: 8,644. THE ORGANIZATION DID NOT, DURING THE YEAR, RECEIVE ANY FUNDS, DIRECTLY,OR INDIRECTLY, TO PAY PREMIUMS ON A PERSONAL BENEFIT CONTRACT.THE ORGANIZATION, DID NOT, DURING THE YEAR, PAY ANY PREMIUMS, DIRECTLY,OR INDIRECTLY, ON A PERSONAL BENEFIT CONTRACT.